Andrew Ancheta is a finance editor who has reported extensively on cryptocurrency, NFTs, economics, and history. He previously worked as an editor for China Daily. Dr. JeFreda R. Brown is a financial ...

Hexaware Technologies today launched a ‘Zero license’ enterprise offering on Tuesday to help organisations replace “bloated” Software-as-a-Service (SaaS) workflows within months by adding an AI layer ...

TL;DR: If you're looking for a powerful productivity suite without recurring subscription fees, Microsoft Office 2021 is available for just $35 for a limited time, an incredible deal. This offer ...

RC Szabo Plumbing & Sewer is proud to announce the expansion of its emergency plumbing and drain services across the Chicago South Suburbs. With over 30 years of family-owned experience, the company ...

AxoGen (NASDAQ:AXGN) reported fourth-quarter and full-year 2025 results that management said marked a “financial inflection point,” citing accelerating adoption of the company’s nerve repair algorithm ...

Looking for an alarm system to make you feel more secure? We've tested all the top professional and DIY home security systems to help you decide which is right to protect your family and property.

Billboard, Eventbrite, Catherine Price, Yoto, Brick, and More Join Movement Championing Analog Connection in a ...

A Malta man is facing animal cruelty-related charges after investigators said two small dogs were found in poor condition at a residence on Route 9. Sex offender charged in Warren County for not ...

OKLAHOMA CITY (KFOR) — Oklahomans will soon see shorter wait times and a simpler process when renewing driver’s licenses, registering vehicles, and completing motor vehicle transactions. Beginning on ...

We are taking a look at HitPaw VikPea AI video enhancer, which offers cleaner footage and restores old videos in one click.

A New York judge on Wednesday allowed DNA evidence obtained through advanced techniques into the forthcoming murder trial of Rex Heuermann, the man accused of being Long Island’s Gilgo Beach serial ...

Mesoblast (NASDAQ:MESO) executives highlighted strong early commercial momentum for its cell therapy Ryoncil and outlined multiple regulatory and clinical milestones ahead during the company’s ...